Lou Gehrig’s disease

Eva Feldman

FDA Approves Phase II Of U-M Stem Cell Trial For ALS

For nearly two years, University of Michigan neurologist Eva Feldman, M.D., has led the nation’s first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig’s disease.

WWJ Newsradio 950–04/17/2013

Emily Kreger emerges from the English Channel after swimming the last leg of the relay.

Michigan Women Break World Record Swimming The English Channel

An amazing story of courage and determination has resulted in a new world record.

WWJ Newsradio 950–07/28/2012

University of Michigan Hospital (University of Michigan photo)

ALS Patients Approved For More Stem Cells

Three patients with amyotrophic lateral sclerosis will be permitted to receive a second dose of stem cells delivered directly to the spinal cord, in a clinical trial being led by the University of Michigan’s Eva Feldman, M.D.

WWJ Newsradio 950–05/09/2012

Synthetics Biologics

Synthetic Biologics Launches Free Investor Relations Mobile Application

Synthetic Biologics Inc. (NYSE Amex: SYN) Thursday announced the release of its investor relations mobile iPhone App, called the “SYN IR” App, now available for free at the Apple App Store on the iPhone or iPad or at http://bit.ly/I9xDpW.

WWJ Newsradio 950–04/26/2012

istockphoto

UM Part Of New Study Of Stem Cell Injections in Lou Gehrig’s Disease

The first published results from an early-stage clinical trial show that spinal cord stem cells can be delivered safely into the spines of patients with the condition commonly known as Lou Gehrig’s disease, opening the door for further research on this innovative approach.

WWJ Newsradio 950–04/10/2012

adeona2

Adeona Names New Managers, Eyes Name Change

Adeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig’s disease. It’s also considering a new business focus and a name change.

WWJ Newsradio 950–02/06/2012

adeona2

Adeona Reports Positive Study Results For Zinc Treatment Of ALS

Pharma startup Adeona and its research partner report no safety issues related to high doses of zinc to slow the effects of Lou Gehrig’s Disease

WWJ Newsradio 950–11/30/2011

adeona2

Adeona Loss Grows, But Drug Trials Continue

The pharma startup Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, reported its third quarter 2011 financial results Monday.

WWJ Newsradio 950–11/14/2011

Hundreds To Walk For ALS Fundraiser

Hundreds of people across southeast Michigan are going to “Walk and Roll” for ALS on Sunday at Kensington Metropark in Milford and Stony Creek Metropark in Shelby Township.

WWJ Newsradio 950–09/24/2011

adeona2

Adeona Loss Grows, But Milestones Reached

Ann Arbor-based Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of medicines for serious central nervous system diseases, Monday reported its second quarter financial results for the period ended June 30, as well as updates since the beginning of the second quarter.

WWJ Newsradio 950–08/15/2011

more

Follow

Get every new post delivered to your Inbox.

Join 2,301 other followers